| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | MITOPOWER LLC | 2671 MARSHALL DR | EAST PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 001 | 3 | NIH | 10/8/2024 | $73,706 |
| | 2025 | 2022 | MITOPOWER LLC | 2671 MARSHALL DR | EAST PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 000 | 2 | NIH | 10/8/2024 | -$73,706 |
|
| Issue Date FY: 2024 ( Subtotal = $1,500,000 ) |
| | 2024 | 2024 | MITOPOWER LLC | 2671 MARSHALL DR | EAST PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 000 | 4 | NIH | 8/5/2024 | $1,500,000 |
|
| Issue Date FY: 2023 ( Subtotal = $1,500,000 ) |
| | 2023 | 2023 | MITOPOWER LLC | 2671 MARSHALL DR | EAST PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 000 | 3 | NIH | 9/5/2023 | $1,500,000 |
|
| Issue Date FY: 2022 ( Subtotal = $1,000,000 ) |
| | 2022 | 2022 | MITOPOWER LLC | 2671 MARSHALL DR | PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 000 | 2 | NIH | 8/22/2022 | $1,000,000 |
| | 2022 | 2021 | MITOPOWER LLC | 2671 MARSHALL DR | PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 001 | 1 | NIH | 8/24/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $985,224 ) |
| | 2021 | 2021 | MITOPOWER LLC | 2671 MARSHALL DR | PALO ALTO | CA | 94303-3654 | SANTA CLARA | USA | U44AA029833 | Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | 000 | 1 | NIH | 9/24/2021 | $985,224 |
|
|
